In real life, one-quarter of patients with hormone receptor-positive metastatic breast cancer receive chemotherapy as initial palliative therapy: a study of the Southeast Netherlands Breast Cancer Consortium-Reference-Cited by-同舟云学术

In real life, one-quarter of patients with hormone receptor-positive metastatic breast cancer receive chemotherapy as initial palliative therapy: a study of the Southeast Netherlands Breast Cancer Consortium

Published:2016-02 Issue:2 Volume:27 Page:256-262
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Lobbezoo D.J.A.,van Kampen R.J.W.,Voogd A.C.,Dercksen M.W.,van den Berkmortel F.,Smilde T.J.,van de Wouw A.J.,Peters F.P.J.,van Riel J.M.G.H.,Peters N.A.J.B.,de Boer M.,Peer P.G.M.,Tjan-Heijnen V.C.G.

Funder

Netherlands Organization for Health Research and Development

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/27/2/256/6675974/mdv544.pdf

Reference25 articles.

1. Trends in survival over the past two decades among white and black patients with newly diagnosed stage IV breast cancer;Dawood;J Clin Oncol,2008

2. The impact of new chemotherapeutic and hormone agents on survival in a population-based cohort of women with metastatic breast cancer;Chia;Cancer,2007

3. Third consensus on medical treatment of metastatic breast cancer;Beslija;Ann Oncol,2009